207 related articles for article (PubMed ID: 23202613)
1. Rationale and design of the 'MITOCARE' Study: a phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
MITOCARE Study Group
Cardiology; 2012; 123(4):201-7. PubMed ID: 23202613
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results.
Atar D; Arheden H; Berdeaux A; Bonnet JL; Carlsson M; Clemmensen P; Cuvier V; Danchin N; Dubois-Randé JL; Engblom H; Erlinge D; Firat H; Halvorsen S; Hansen HS; Hauke W; Heiberg E; Koul S; Larsen AI; Le Corvoisier P; Nordrehaug JE; Paganelli F; Pruss RM; Rousseau H; Schaller S; Sonou G; Tuseth V; Veys J; Vicaut E; Jensen SE
Eur Heart J; 2015 Jan; 36(2):112-9. PubMed ID: 25179768
[TBL] [Abstract][Full Text] [Related]
3. Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins.
Butt N; Bache-Mathiesen LK; Nordrehaug JE; Tuseth V; Munk PS; Bonarjee V; Hall TS; Jensen SE; Halvorsen S; Firat H; Atar D; Larsen AI
Cardiology; 2017; 138(2):122-132. PubMed ID: 28651249
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
Chakrabarti AK; Feeney K; Abueg C; Brown DA; Czyz E; Tendera M; Janosi A; Giugliano RP; Kloner RA; Weaver WD; Bode C; Godlewski J; Merkely B; Gibson CM
Am Heart J; 2013 Apr; 165(4):509-514.e7. PubMed ID: 23537966
[TBL] [Abstract][Full Text] [Related]
5. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
Ishihara M; Asakura M; Kimura K; Nakao K; Hamada C; Hirayama A
J Cardiol; 2014 Jan; 63(1):82-7. PubMed ID: 23860273
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Atar D; Huber K; Rupprecht HJ; Kopecky SL; Schwitter J; Theek C; Brandl K; Henning R; Geudelin B
Cardiology; 2007; 108(2):117-23. PubMed ID: 17019083
[TBL] [Abstract][Full Text] [Related]
7. Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial.
Le Lamer S; Paradis S; Rahmouni H; Chaimbault C; Michaud M; Culcasi M; Afxantidis J; Latreille M; Berna P; Berdeaux A; Pietri S; Morin D; Donazzolo Y; Abitbol JL; Pruss RM; Schaller S
J Transl Med; 2014 Feb; 12():38. PubMed ID: 24507657
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
[TBL] [Abstract][Full Text] [Related]
9. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
10. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
11. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
Bresson D; Roubille F; Prieur C; Biere L; Ivanes F; Bouleti C; Dubreuil O; Rioufol G; Boutitie F; Sideris G; Elbaz M; Bochaton T; De Bourguignon C; El Jonhy N; Dufay N; Dhelens C; Croisille P; Prunier F; Angoulvant D; Ovize M; Maucort-Boulch D; Mewton N
Cardiology; 2021; 146(2):151-160. PubMed ID: 33582664
[TBL] [Abstract][Full Text] [Related]
12. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial.
Le Corvoisier P; Gallet R; Lesault PF; Audureau E; Paul M; Ternacle J; Ghostine S; Champagne S; Arrouasse R; Bitari D; Mouillet G; Dubois-Randé JL; Berdeaux A; Ghaleh B; Deux JF; Teiger E
BMC Cardiovasc Disord; 2018 Oct; 18(1):193. PubMed ID: 30340532
[TBL] [Abstract][Full Text] [Related]
13. Differences in the profile of protection afforded by TRO40303 and mild hypothermia in models of cardiac ischemia/reperfusion injury.
Hansson MJ; Llwyd O; Morin D; de Paulis D; Arnoux T; Gouarné C; Koul S; Engblom H; Bordet T; Tissier R; Arheden H; Erlinge D; Halestrap AP; Berdeaux A; Pruss RM; Schaller S
Eur J Pharmacol; 2015 Aug; 760():7-19. PubMed ID: 25895640
[TBL] [Abstract][Full Text] [Related]
14. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
Lincoff AM; Roe M; Aylward P; Galla J; Rynkiewicz A; Guetta V; Zelizko M; Kleiman N; White H; McErlean E; Erlinge D; Laine M; Dos Santos Ferreira JM; Goodman S; Mehta S; Atar D; Suryapranata H; Jensen SE; Forster T; Fernandez-Ortiz A; Schoors D; Radke P; Belli G; Brennan D; Bell G; Krucoff M;
Eur Heart J; 2014 Oct; 35(37):2516-23. PubMed ID: 24796339
[TBL] [Abstract][Full Text] [Related]
16. Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI).
Siddiqi N; Neil C; Bruce M; MacLennan G; Cotton S; Papadopoulou S; Feelisch M; Bunce N; Lim PO; Hildick-Smith D; Horowitz J; Madhani M; Boon N; Dawson D; Kaski JC; Frenneaux M;
Eur Heart J; 2014 May; 35(19):1255-62. PubMed ID: 24639423
[TBL] [Abstract][Full Text] [Related]
17. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Lønborg J; Vejlstrup N; Kelbæk H; Bøtker HE; Kim WY; Mathiasen AB; Jørgensen E; Helqvist S; Saunamäki K; Clemmensen P; Holmvang L; Thuesen L; Krusell LR; Jensen JS; Køber L; Treiman M; Holst JJ; Engstrøm T
Eur Heart J; 2012 Jun; 33(12):1491-9. PubMed ID: 21920963
[TBL] [Abstract][Full Text] [Related]
18. Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center.
Nozari Y; Eshraghi A; Talasaz AH; Bahremand M; Salamzadeh J; Salarifar M; Pourhosseini H; Jalali A; Mortazavi SH
Am J Cardiovasc Drugs; 2018 Jun; 18(3):213-221. PubMed ID: 29322434
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial.
Rodrigo R; Hasson D; Prieto JC; Dussaillant G; Ramos C; León L; Gárate J; Valls N; Gormaz JG
Trials; 2014 May; 15():192. PubMed ID: 24885600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
